Editas Medicine, Inc.
EDIT
$2.65
$0.010.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 67.17% | 87.62% | 59.58% | 21.26% | -22.82% |
| Total Depreciation and Amortization | -74.80% | -74.61% | 477.49% | 29.15% | 36.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -62.49% | -53.95% | -15.54% | 113.96% | 49.21% |
| Change in Net Operating Assets | -110.49% | -174.50% | -353.79% | -172.07% | 266.98% |
| Cash from Operations | 51.75% | 28.32% | 41.35% | 12.00% | 4.16% |
| Capital Expenditure | 19.30% | 88.89% | 85.18% | 100.00% | 93.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -53.96% | -23.35% | 2,065.94% |
| Cash from Investing | -99.89% | -99.81% | -52.88% | -17.91% | 1,288.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 6,340.89% | -- | 2,201.86% | 647.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Financing | -- | -68.79% | -- | 2,201.86% | -848.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -421.59% | -153.22% | -17.50% | 96.87% | 113.14% |